Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.

Jorge J CastilloAdam J Olszewski Zachary R HunterSandra KananKirsten MeidSteven P Treon

Published in: Cancer (2015)

Patients with WM had a 49% higher risk of SMs than the general population. The selectively increased risk for hematologic SMs and certain solid SMs may be associated with transformation, therapy, and immune dysregulation.

Keyphrases

stem cells
emergency department
cell therapy
smoking cessation